Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics.

[1]  Atsuhiko Sumii,et al.  Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer , 2022, International Journal of Clinical Oncology.

[2]  M. Ohue,et al.  Combination of extramural venous invasion and lateral lymph node size detected with magnetic resonance imaging is a reliable biomarker for lateral lymph node metastasis in patients with rectal cancer , 2022, World Journal of Surgical Oncology.

[3]  G. Beets,et al.  Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases , 2021, Annals of Surgical Oncology.

[4]  Zhixiang Zhou,et al.  Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications , 2021, Journal of surgical oncology.

[5]  Zongguang Zhou,et al.  Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging , 2021, Techniques in Coloproctology.

[6]  S. Ishihara,et al.  Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy For Rectal Cancer. , 2020, Diseases of the colon and rectum.

[7]  Jianjun He,et al.  Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors , 2020, Annals of Surgical Oncology.

[8]  K. Oba,et al.  Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer , 2020, Annals of Surgical Oncology.

[9]  M. Ohue,et al.  Development of a novel prediction model for recurrent stage II colon cancer , 2019, Surgery Today.

[10]  E. Holliday,et al.  Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? , 2019, Diseases of the colon and rectum.

[11]  H. Putter,et al.  Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. , 2019, JAMA surgery.

[12]  N. Haboubi,et al.  Extramural spread of rectal cancer and the AJCC Cancer Staging Manual 8th Edition, 2017. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  P. Wang,et al.  Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy , 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[14]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.

[15]  N. Hoshino,et al.  Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis , 2018, International Journal of Clinical Oncology.

[16]  Y. Toiyama,et al.  Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer. , 2016, Molecular and clinical oncology.

[17]  K. Jhaveri,et al.  MRI Detection of Extramural Venous Invasion in Rectal Cancer: Correlation With Histopathology Using Elastin Stain. , 2016, AJR. American journal of roentgenology.

[18]  Tae Hyun Kim,et al.  Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? , 2015, Journal of surgical oncology.

[19]  PhD Shingo Kameoka MD,et al.  Selection of Lymph Node–Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum , 2015, Annals of Surgical Oncology.

[20]  J. Park,et al.  Neoadjuvant Chemoradiotherapy Affects the Indications for Lateral Pelvic Node Dissection in Mid/Low Rectal Cancer with Clinically Suspected Lateral Node Involvement: A Multicenter Retrospective Cohort Study , 2014, Annals of Surgical Oncology.

[21]  L. Collette,et al.  Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. , 2014, The Lancet. Oncology.

[22]  Gina Brown,et al.  Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Sung Ho Moon,et al.  Lateral Lymph Node Metastasis Is a Major Cause of Locoregional Recurrence in Rectal Cancer Treated with Preoperative Chemoradiotherapy and Curative Resection , 2007, Annals of Surgical Oncology.

[24]  Y. Atomi,et al.  Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. , 2007, Anticancer research.

[25]  K. Shirouzu,et al.  Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer , 2006, Diseases of the colon and rectum.